Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
The Journal of Reproductive Medicine
|
September 8, 2001
Treatment of vulvar vestibulitis with submucous infiltrations of methylprednisolone and lidocaine. An alternative approach
F Murina, P Tassan, P Roberti, et al.
Minerva Ginecologica
|
September 8, 2006
Tibolone in the treatment of menopause: compliance, efficacy and safety in a ten year experience
V Bianco, F Murina, P Roberti, et al.
Frontiers in Immunology
|
December 19, 2012
Biological role of NK cells and immunotherapeutic approaches in breast cancer
María P Roberti, José Mordoh, Estrella M Levy
Minerva Pediatrica
|
November 1, 1993
[Vulvo-vaginitis in pediatric age]
S Beolchi, C Brambilla, P Roberti, et al.
Journal of Chromatography. A
|
March 5, 2003
Determination of enrofloxacin and its metabolite ciprofloxacin in goat milk by high-performance liquid chromatography with diode-array detection. Optimization and validation
A L Cinquina, P Roberti, L Giannetti, et al.
Breast Cancer Research and Treatment
|
February 11, 2011
IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR
M P Roberti, M M Barrio, A I Bravo, et al.
Innate Immunity
|
July 12, 2012
Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients
Yamila S Rocca, María P Roberti, Juan M Arriaga, et al.
Cancer Immunology, Immunotherapy : CII
|
June 23, 2012
High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function
Gabriela A Pizzurro, Florencia P Madorsky Rowdo, Luciana M Pujol-Lereis, et al.
European Journal of Immunology
|
March 3, 2015
Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade
María P Roberti, Estefanía P Juliá, Yamila S Rocca, et al.
Breast Cancer Research and Treatment
|
October 16, 2012
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients
María P Roberti, Yamila S Rocca, Mora Amat, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
The Journal of Reproductive Medicine
|
September 8, 2001
Treatment of vulvar vestibulitis with submucous infiltrations of methylprednisolone and lidocaine. An alternative approach
F Murina, P Tassan, P Roberti, et al.
Minerva Ginecologica
|
September 8, 2006
Tibolone in the treatment of menopause: compliance, efficacy and safety in a ten year experience
V Bianco, F Murina, P Roberti, et al.
Frontiers in Immunology
|
December 19, 2012
Biological role of NK cells and immunotherapeutic approaches in breast cancer
María P Roberti, José Mordoh, Estrella M Levy
Minerva Pediatrica
|
November 1, 1993
[Vulvo-vaginitis in pediatric age]
S Beolchi, C Brambilla, P Roberti, et al.
Journal of Chromatography. A
|
March 5, 2003
Determination of enrofloxacin and its metabolite ciprofloxacin in goat milk by high-performance liquid chromatography with diode-array detection. Optimization and validation
A L Cinquina, P Roberti, L Giannetti, et al.
Breast Cancer Research and Treatment
|
February 11, 2011
IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR
M P Roberti, M M Barrio, A I Bravo, et al.
Innate Immunity
|
July 12, 2012
Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients
Yamila S Rocca, María P Roberti, Juan M Arriaga, et al.
Cancer Immunology, Immunotherapy : CII
|
June 23, 2012
High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function
Gabriela A Pizzurro, Florencia P Madorsky Rowdo, Luciana M Pujol-Lereis, et al.
European Journal of Immunology
|
March 3, 2015
Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade
María P Roberti, Estefanía P Juliá, Yamila S Rocca, et al.
Breast Cancer Research and Treatment
|
October 16, 2012
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients
María P Roberti, Yamila S Rocca, Mora Amat, et al.
Page
of 2